Navigation Links
Hormonal Disorder Linked to Pregnancy Complications: Study
Date:10/14/2011

FRIDAY, Oct. 14 (HealthDay News) -- A common hormonal disorder among women known as polycystic ovary syndrome (PCOS) seems to be associated with an increased risk for pregnancy complications, such as preeclampsia, diabetes and premature birth, a new study indicates.

PCOS affects between 5 percent and 15 percent of women of reproductive age, according to background information in the study published in the Oct. 13 online edition of BMJ. Symptoms include irregular periods, ovulation problems, weight gain and excessive hair growth, and women with the disorder typically have small cysts on their ovaries.

In the study, Swedish researchers compared just under 3,800 births among women with PCOS with nearly 1.2 million births among women without the condition, and found that women with PCOS were more likely to be obese and to use assisted reproductive technology.

Women with PCOS were 45 percent more likely to experience preeclampsia (a condition that causes high blood pressure in pregnant women) and more than twice as likely to develop diabetes during pregnancy and/or to give birth prematurely, compared to women without PCOS, the investigators found.

In addition, babies born to women with PCOS were more likely to be large for gestational age and tended to develop asphyxia (a lack of oxygen) during labor, according to Nathalie Roos and colleagues at the Karolinska Institute and Karolinska University Hospital in Stockholm.

The increased risk of pregnancy complications among women with PCOS could not be attributed to advanced age, being overweight or obese, or the use of assisted reproductive technology, the researchers pointed out in a journal news release.

"These women may need increased surveillance during pregnancy and childbirth. Future research would benefit from focusing on glucose control, medical treatment and hormonal status among women with polycystic ovary syndrome during pregnancy," the researchers concluded.

"It is clear that women with polycystic ovary syndrome should be considered 'high risk' obstetric patients and that midwives, general practitioners and obstetricians should monitor these women as such," Nick Macklon, of the University of Southampton in England, wrote in an accompanying editorial.

However, "more evidence is required to support the use of currently used interventions designed to reduce perinatal risk, and this requires a greater understanding of the different polycystic ovary syndrome phenotypes and the underlying mechanisms by which this common condition alters pregnancy outcomes," Macklon added.

More information

The U.S. National Institute of Child Health and Human Development has more about polycystic ovary syndrome.

-- Robert Preidt

SOURCE: BMJ, news release, Oct. 13, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Fewer than half of breast cancer patients adhere to hormonal therapy regimen, study finds
2. Side effects of hormonal breast cancer therapy increased; may affect treatment adherence
3. New hope for advanced post-menopausal breast cancer patients resistant to hormonal therapy
4. UH researchers explain hormonal role in glucose and fat metabolism
5. People with anxiety disorder less able to regulate response to negative emotions, study shows
6. NIH grants to Childrens Hospital will advance novel stem cell treatments for blood disorders
7. Tennessee Orofacial Myology, LLC is the First Office to Open in Tennessee to Help Patients with Orofacial Disorders
8. Anxiety Disorder Patients Process Emotions Differently
9. Figure Skating Standards Foster Eating Disorders, Says Kimberly Dennis, M.D.
10. Remuda Ranch Programs for Eating and Anxiety Disorders Sponsors a Special Edition of the Award-Winning Documentary America The Beautiful
11. Visual Cues that Improve Walking for People with Movement Disorders - Study Shows Small Change in Arrangement Can Make a Big Difference in Improvement Gained
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Hormonal Disorder Linked to Pregnancy Complications: Study
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Yisrayl Hawkins, ... week that explains one of the most popular and least understood books in the ... cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed it ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains ... possible to save lost souls in the Philippines. “The Journey: From the Mountains to ... dedicated teacher of the Bible. She has taught all ages and currently teaches a ...
(Date:10/12/2017)... ... 12, 2017 , ... CitiDent and San Francisco dentists, Dr. ... Oventus O2Vent technology. As many as 18 million Americans are estimated to suffer ... Oral appliances can offer significant relief to about 75 percent of people with ...
(Date:10/12/2017)... ... ... IsoComforter, Inc. ( https://isocomforter.com ), one of the Nation’s premier ... of the shoulder pad. The shoulder pad provides optimal support and full contact ... using cold therapy. By utilizing ice and water that is circulated from an insulated ...
(Date:10/12/2017)... Maryland (PRWEB) , ... October 12, 2017 , ... ... magnetic drug delivery system that we intend to develop to enable prevention of ... can lead to severe hearing loss, especially in pediatric patients. For cisplatin, hearing ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... R.I. , Sept. 25, 2017  EpiVax, ... assessment, vaccine design, and immune-engineering today announced the ... on the development of personalized therapeutic cancer vaccines. ... has provided exclusive access to enabling technologies to ... Eng., MBA will lead EpiVax Oncology as Chief ...
(Date:9/19/2017)... , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing a ... targeted tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek , ...
(Date:9/13/2017)... , Sept. 13, 2017   OrthoAtlanta has been ... Atlanta Football Host Committee (AFHC) for the 2018 College Football ... 8, 2018, at Mercedes-Benz Stadium in Atlanta, Georgia ... the AFHC "I,m In" campaign, participating in many activities leading ... ...
Breaking Medicine Technology: